ML40006 HEROLD
A prospective, non-interventional study assessing the diagnostic, therapeutic proceedings and safety of anti-HER2 treatment in elderly patients (≥70 years old) with HER2 positive breast cancer
in routine clinical practice in Poland
- multicenter, observational study.